170 related articles for article (PubMed ID: 32107736)
21. A randomized controlled trial of an exercise intervention targeting cardiovascular and metabolic risk factors for prostate cancer patients from the RADAR trial.
Galvão DA; Spry N; Taaffe DR; Denham J; Joseph D; Lamb DS; Levin G; Duchesne G; Newton RU
BMC Cancer; 2009 Dec; 9():419. PubMed ID: 19951446
[TBL] [Abstract][Full Text] [Related]
22. Aerobic and strength training exercise programme for cognitive impairment in people with mild to moderate dementia: the DAPA RCT.
Lamb SE; Mistry D; Alleyne S; Atherton N; Brown D; Copsey B; Dosanjh S; Finnegan S; Fordham B; Griffiths F; Hennings S; Khan I; Khan K; Lall R; Lyle S; Nichols V; Petrou S; Zeh P; Sheehan B
Health Technol Assess; 2018 May; 22(28):1-202. PubMed ID: 29848412
[TBL] [Abstract][Full Text] [Related]
23. Supervised neuromuscular exercise prior to hip and knee replacement: 12-month clinical effect and cost-utility analysis alongside a randomised controlled trial.
Fernandes L; Roos EM; Overgaard S; Villadsen A; Søgaard R
BMC Musculoskelet Disord; 2017 Jan; 18(1):5. PubMed ID: 28061841
[TBL] [Abstract][Full Text] [Related]
24. Effects of Different Exercise Modalities on Fatigue in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy: A Year-long Randomised Controlled Trial.
Taaffe DR; Newton RU; Spry N; Joseph D; Chambers SK; Gardiner RA; Wall BA; Cormie P; Bolam KA; Galvão DA
Eur Urol; 2017 Aug; 72(2):293-299. PubMed ID: 28249801
[TBL] [Abstract][Full Text] [Related]
25. Cost-Effectiveness of Adding Androgen Deprivation Therapy to Radiation Therapy for Men with Advanced Prostate Cancer from a U.S. Payer's Perspective.
Nguyen C; Lairson DR; Swartz MD; Du XL
J Manag Care Spec Pharm; 2019 Feb; 25(2):225-234. PubMed ID: 30698095
[TBL] [Abstract][Full Text] [Related]
26. Long-term effectiveness and cost-effectiveness of high versus low-to-moderate intensity resistance and endurance exercise interventions among cancer survivors.
Kampshoff CS; van Dongen JM; van Mechelen W; Schep G; Vreugdenhil A; Twisk JWR; Bosmans JE; Brug J; Chinapaw MJM; Buffart LM
J Cancer Surviv; 2018 Jun; 12(3):417-429. PubMed ID: 29497963
[TBL] [Abstract][Full Text] [Related]
27. Lifestyle changes for improving disease-specific quality of life in sedentary men on long-term androgen-deprivation therapy for advanced prostate cancer: a randomised controlled trial.
Bourke L; Gilbert S; Hooper R; Steed LA; Joshi M; Catto JW; Saxton JM; Rosario DJ
Eur Urol; 2014 May; 65(5):865-72. PubMed ID: 24119318
[TBL] [Abstract][Full Text] [Related]
28. Clinical effectiveness and cost-effectiveness of a multifaceted podiatry intervention for falls prevention in older people: a multicentre cohort randomised controlled trial (the REducing Falls with ORthoses and a Multifaceted podiatry intervention trial).
Cockayne S; Rodgers S; Green L; Fairhurst C; Adamson J; Scantlebury A; Corbacho B; Hewitt CE; Hicks K; Hull R; Keenan AM; Lamb SE; McIntosh C; Menz HB; Redmond A; Richardson Z; Vernon W; Watson J; Torgerson DJ
Health Technol Assess; 2017 Apr; 21(24):1-198. PubMed ID: 28621259
[TBL] [Abstract][Full Text] [Related]
29. Cost-effectiveness of Prostate Radiation Therapy for Men With Newly Diagnosed Low-Burden Metastatic Prostate Cancer.
Lester-Coll NH; Ades S; Yu JB; Atherly A; Wallace HJ; Sprague BL
JAMA Netw Open; 2021 Jan; 4(1):e2033787. PubMed ID: 33439266
[TBL] [Abstract][Full Text] [Related]
30. Cost-effectiveness analysis of degarelix for advanced hormone-dependent prostate cancer.
Lu L; Peters J; Roome C; Stein K
BJU Int; 2012 Apr; 109(8):1183-92. PubMed ID: 21883830
[TBL] [Abstract][Full Text] [Related]
31. Cost-effectiveness of a pragmatic exercise intervention for women with breast cancer: results from a randomized controlled trial.
Gordon LG; DiSipio T; Battistutta D; Yates P; Bashford J; Pyke C; Eakin E; Hayes SC
Psychooncology; 2017 May; 26(5):649-655. PubMed ID: 27338125
[TBL] [Abstract][Full Text] [Related]
32. Economic evaluation of a brief education, self-management and upper limb exercise training in people with rheumatoid arthritis (EXTRA) programme: a trial-based analysis.
Manning VL; Kaambwa B; Ratcliffe J; Scott DL; Choy E; Hurley MV; Bearne LM
Rheumatology (Oxford); 2015 Feb; 54(2):302-9. PubMed ID: 25173349
[TBL] [Abstract][Full Text] [Related]
33. Cost-Effectiveness Analysis from a Randomized Controlled Trial of Tailored Exercise Prescription for Women with Breast Cancer with 8-Year Follow-Up.
Gordon LG; Eakin EG; Spence RR; Pyke C; Bashford J; Saunders C; Hayes SC
Int J Environ Res Public Health; 2020 Nov; 17(22):. PubMed ID: 33228174
[TBL] [Abstract][Full Text] [Related]
34. Long-term efficacy and cost-effectiveness of blended cognitive behavior therapy for high fear of recurrence in breast, prostate and colorectal Cancer survivors: follow-up of the SWORD randomized controlled trial.
Burm R; Thewes B; Rodwell L; Kievit W; Speckens A; van de Wal M; Prins J
BMC Cancer; 2019 May; 19(1):462. PubMed ID: 31096934
[TBL] [Abstract][Full Text] [Related]
35. Decision analytic cost-effectiveness model to compare prostate cryotherapy to androgen deprivation therapy for treatment of radiation recurrent prostate cancer.
Boyd KA; Jones RJ; Paul J; Birrell F; Briggs AH; Leung HY
BMJ Open; 2015 Oct; 5(10):e007925. PubMed ID: 26482768
[TBL] [Abstract][Full Text] [Related]
36. Cost effectiveness of a pragmatic exercise intervention (EXIMS) for people with multiple sclerosis: economic evaluation of a randomised controlled trial.
Tosh J; Dixon S; Carter A; Daley A; Petty J; Roalfe A; Sharrack B; Saxton JM
Mult Scler; 2014 Jul; 20(8):1123-30. PubMed ID: 24421304
[TBL] [Abstract][Full Text] [Related]
37. Moderators of resistance-based exercise programs' effect on sarcopenia-related measures in men with prostate cancer previously or currently undergoing androgen deprivation therapy: An individual patient data meta-analysis.
Lopez P; Newton RU; Taaffe DR; Winters-Stone K; Galvão DA; Buffart LM
J Geriatr Oncol; 2023 Jun; 14(5):101535. PubMed ID: 37229882
[TBL] [Abstract][Full Text] [Related]
38. Effects of a Group-Mediated Cognitive Behavioral Lifestyle Intervention on Select Social Cognitive Outcomes in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy.
Focht BC; Lucas AR; Grainger E; Simpson C; Fairman CM; Thomas-Ahner JM; Chaplow ZL; DeScenza VR; Bowman J; Clinton SK
Integr Cancer Ther; 2019; 18():1534735419893764. PubMed ID: 31838879
[No Abstract] [Full Text] [Related]
39. Cost-Effectiveness and Cost-Utility of a Home-Based Exercise Program in Geriatric Patients with Cognitive Impairment.
Eckert T; Wronski P; Bongartz M; Ullrich P; Abel B; Kiss R; Wensing M; Koetsenruijter J; Hauer K
Gerontology; 2021; 67(2):220-232. PubMed ID: 33503629
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
